9667

540937

MEDICO

img img img img
No Data Available

MEDICO REMEDIES LIMITED Share Price Update

As of the latest trading session, MEDICO REMEDIES LIMITED share price is currently at ₹44.6, which is down by ₹-0.40 from its previous closing. Today, the stock has fluctuated between ₹43.91 and ₹45.50. Over the past year, MEDICO REMEDIES LIMITED has achieved a return of -10.94%. In the last month alone, the return has been -11.46%.

MEDICO REMEDIES LIMITED performance

Today’s low

Today’s high

₹ 43.91 ₹ 45.50
₹ 44.53

52 week low

52 week high

₹ 37.18 ₹ 63.48
₹ 44.53

Open Price

₹ 45.44

Prev. Close

₹ 45.01

Volume (Shares)

193647.00

Total traded value

₹ 86.23

Upper Circuit

₹ 54.01

Lower Circuit

₹ 36.01

info

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

MEDICO REMEDIES LIMITED fundamentals


  • Market cap (Cr)

    369.50

  • P/E Ratio (TTM)

    32.13

  • Beta

    0.29

  • Book Value / share

    8.05

  • Return on equity

    17.57%

  • EPS (TTM)

    1.40

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    2.87

info icon alternate text
  • Market cap (Cr)

    377.20

  • P/E Ratio (TTM)

    32.13

  • Beta

    0.20

  • Book Value / share

    8.05

  • Return on equity

    17.57%

  • EPS (TTM)

    1.40

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    2.87

info icon alternate text

MEDICO REMEDIES LIMITED Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2025 (Values in Cr)
Revenue 58.68
Operating Expense 55.53
Net Profit 2.87
Net Profit Margin (%) 4.89
Earnings Per Share (EPS) 0.35
EBITDA 5.01
Effective Tax Rate (%) 25.06
Particulars SEP 2025 (Values in Cr)
Revenue 52.64
Operating Expense 50.89
Net Profit 2.57
Net Profit Margin (%) 4.88
Earnings Per Share (EPS) 0.31
EBITDA 4.43
Effective Tax Rate (%) 26.22
Particulars JUN 2025 (Values in Cr)
Revenue 38.25
Operating Expense 36.47
Net Profit 1.82
Net Profit Margin (%) 4.75
Earnings Per Share (EPS) 0.22
EBITDA 3.48
Effective Tax Rate (%) 25.51
Particulars MAR 2025 (Values in Cr)
Revenue 41.30
Operating Expense 35.89
Net Profit 4.34
Net Profit Margin (%) 10.50
Earnings Per Share (EPS) 0.52
EBITDA 6.96
Effective Tax Rate (%) 23.85
Particulars DEC 2024 (Values in Cr)
Revenue 39.49
Operating Expense 37.42
Net Profit 2.62
Net Profit Margin (%) 6.63
Earnings Per Share (EPS) 0.32
EBITDA 4.54
Effective Tax Rate (%) 25.14
Particulars MAR 2025 (Values in Cr)
Revenue 150.94
Operating Expense 140.13
Net Profit 10.09
Net Profit Margin (%) 6.68
Earnings Per Share (EPS) 1.22
EBITDA 17.69
Effective Tax Rate (%) 25.25
Particulars MAR 2024 (Values in Cr)
Revenue 144.92
Operating Expense 135.70
Net Profit 8.29
Net Profit Margin (%) 5.72
Earnings Per Share (EPS) 1.00
EBITDA 15.03
Effective Tax Rate (%) 26.83
Particulars MAR 2023 (Values in Cr)
Revenue 140.44
Operating Expense 134.29
Net Profit 7.24
Net Profit Margin (%) 5.15
Earnings Per Share (EPS) 0.87
EBITDA 13.57
Effective Tax Rate (%) 28.31
Particulars MAR 2022 (Values in Cr)
Revenue 121.02
Operating Expense 116.56
Net Profit 4.81
Net Profit Margin (%) 3.97
Earnings Per Share (EPS) 2.90
EBITDA 9.36
Effective Tax Rate (%) 25.77
Particulars MAR 2021 (Values in Cr)
Revenue 122.39
Operating Expense 119.73
Net Profit 2.59
Net Profit Margin (%) 2.11
Earnings Per Share (EPS) 6.25
EBITDA 6.26
Effective Tax Rate (%) 29.53
Particulars MAR 2025 (Values in Cr)
Book Value / Share 7.53
ROE % 17.57
ROCE % 21.31
Total Debt to Total Equity 0.20
EBITDA Margin 11.72
Particulars MAR 2024 (Values in Cr)
Book Value / Share 6.31
ROE % 17.23
ROCE % 21.24
Total Debt to Total Equity 0.19
EBITDA Margin 10.37
Particulars MAR 2023 (Values in Cr)
Book Value / Share 5.28
ROE % 18.00
ROCE % 21.01
Total Debt to Total Equity 0.28
EBITDA Margin 9.66
Particulars MAR 2022 (Values in Cr)
Book Value / Share 22.04
ROE % 13.93
ROCE % 14.74
Total Debt to Total Equity 0.40
EBITDA Margin 7.73
Particulars MAR 2021 (Values in Cr)
Book Value / Share 78.22
ROE % 8.31
ROCE % 10.11
Total Debt to Total Equity 0.46
EBITDA Margin 5.12
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 1.09
Total Assets 119.79
Total Liabilities 119.79
Total Equity 62.46
Share Outstanding 8
Price to Book Ratio 6.92
Return on Assets (%) 8.42
Return on Capital (%) 13.23
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.18
Total Assets 96.19
Total Liabilities 96.19
Total Equity 52.37
Share Outstanding 8
Price to Book Ratio 7.81
Return on Assets (%) 8.61
Return on Capital (%) 14.02
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.91
Total Assets 87.44
Total Liabilities 87.44
Total Equity 43.84
Share Outstanding 8
Price to Book Ratio 14.15
Return on Assets (%) 8.28
Return on Capital (%) 13.94
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 2.34
Total Assets 77.40
Total Liabilities 77.40
Total Equity 36.57
Share Outstanding 1
Price to Book Ratio 3.81
Return on Assets (%) 6.21
Return on Capital (%) 10.2
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 2.83
Total Assets 75.62
Total Liabilities 75.62
Total Equity 32.46
Share Outstanding 0
Price to Book Ratio 1.28
Return on Assets (%) 3.42
Return on Capital (%) 5.45
Particulars MAR 2025 (Values in Cr)
Net Income 13.50
Cash from Operations 8.69
Cash from Investing -3.45
Cash from Financing -0.52
Net change in Cash 0.91
Free Cash Flow 8.69
Particulars MAR 2024 (Values in Cr)
Net Income 11.33
Cash from Operations 5.60
Cash from Investing -2.67
Cash from Financing -0.49
Net change in Cash -0.72
Free Cash Flow 5.60
Particulars MAR 2023 (Values in Cr)
Net Income 10.09
Cash from Operations 10.66
Cash from Investing -6.60
Cash from Financing -1.81
Net change in Cash -0.25
Free Cash Flow 10.66
Particulars MAR 2022 (Values in Cr)
Net Income 6.48
Cash from Operations 7.65
Cash from Investing -1.75
Cash from Financing -5.77
Net change in Cash -1.66
Free Cash Flow 7.65
Particulars MAR 2021 (Values in Cr)
Net Income 2.59
Cash from Operations -10.38
Cash from Investing -16.96
Cash from Financing 18.28
Net change in Cash -9.99
Free Cash Flow 6.58
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 26.32 11.39 1.36 201.70 23.12 / 42.05
BLISS GVS PHARMA LTD 217.50 20.79 2.03 2300.91 105.05 / 244.05
CIPLA LTD 1357.80 23.07 3.33 109680.46 1283.00 / 1672.20
FERMENTA BIOTECH LIMITED 332.45 11.06 2.50 978.43 219.00 / 399.00
GLAXOSMITHKLINE PHARMA LT 2624.85 44.21 26.03 44466.54 2220.00 / 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 26.32 25.31 3.66 201.70 23.12 / 42.05
AMRUTAJAN HEALTH LTD 606.35 30.32 5.12 1753.00 548.05 / 789.95
ASTRAZENECA PHARMA IND LT 8850.60 106.36 27.69 22126.50 6501.60 / 10653.05
BLISS GVS PHARMA LTD 217.50 29.63 2.08 2300.91 105.05 / 244.05

MEDICO REMEDIES LIMITED shareholding pattern

Holding

38.12%
61.38%
0.49%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

MEDICO REMEDIES LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
44.53 -1.06 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 45.90
  • 26 Days 47.60
  • 10 Days 46.50
  • 50 Days 48.40
  • 12 Days 46.70
  • 100 Days 48.60
  • 20 Days 47.30
  • 200 Days 48.80
45.50 PIVOT

First Support

44.24

First Resistance

46.28

Second Support

43.46

Second Resistance

47.54

Third Support

42.20

Third Resistance

48.32

RSI

40.32

ADX

10.70

MACD

-0.92

Williams % R

-95.53

Commodity Channel Index (CCI)

-150.70

Date

2026-02-26

Week

46739.00

Same Day

110475.00

Month

132682.00

1 Year

0.30

3 Year

0.40

Over 1 Month

-11.46%

down

Over 1 Year

-10.94%

down

Over 3 Months

-9.61%

down

Over 3 Years

-12.85%

down

Over 6 Months

13.17%

down

Over 5 Years

0.00%

down

MEDICO REMEDIES LIMITED Corporate Actions

Ex-Date Ex-Bonus Ratio
17 Nov 2021 16 Nov 2021 3:1
Ex-Date Old FV NEW FV Record Date
16 Mar 2023 10.0 2.0 16 Mar 2023
Ex-Date Ex-Bonus Ratio
17 Nov 2021 16 Nov 2021 3:1
Ex-Date Old FV NEW FV Record Date
16 Mar 2023 10.0 2.0 16 Mar 2023

Top Gainers

MEDICO REMEDIES LIMITED Share Price

Medico Remedies Limited was incorporated as a Private Limited Company as 'Medico Remedies Private Limited' on March 18, 1994. The status was changed to a Public Company and the name of the Company was changed to Medico Remedies Limited on March 6, 2017.

Medico Remedies is a pharmaceutical formulation manufacturing company with manufacturing and marketing capabilities in formulation with focus on anti-infective, Beta-Lactums, cephalosporins, antimalarial, antiretroviral, anti-ulcer drugs and antacids, vitamins, haematinics and other supplements. Further in addition to above, the Company also has manufacturing and marketing capabilities in other drugs such as NSAIDS, Antihistaminic, Antidiabetics, Cardio Vascular Drugs, Diuretics, Anti-Epileptics, combination drug kits, syrups and cream & gel for various therapeutic segments.

The Company began its operations in 1994 with manufacturing and servicing of diuretics, anti-malarials, NSAIDS tablets, anti-reterovirals, anti-ulcer drugs and anti-acids tablets. Over the years the company has expanded its scale and scope of operations and currently the Company is engaged in manufacture of formulations for various medicines. As part of this expansion, in year 1999 & 2002, Company has a manufacturing facility for the manufacture of its products located in the State of Maharashtra at Palghar.. The plant is divided into two units, i.e. general formulations unit and beta-lactam unit; the beta lactam unit is further divided into two segments -Penicillin and Cephalosporins.

The Company has built a strong relationship with its customers for drug formulations. The clients include Indian as well as foreign pharmaceutical companies like Anphar Limited, Saad Medical, Manfes Pharmaceuticals & Chemical Industries, Award Global Company Limited, Directorate of Health Services (DHS, Maharashtra) to name a few. The Company also earns revenue from the sale of licenses such as FMS license, FPS license and MESI license.

In 2018-19, the Company purchased adjoining manufacturing unit with existing factory at Palghar.

In January 2018, the Company came up with a Public Issue of 10,99,200 Equity Shares by raising equity capital amounting to Rs 10.99 Crores.

Parent organization Indian Private
NSE symbol MEDICO
Founded 1994
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Medico Remedies Ltd?

Answer Field

Medico Remedies Ltd share price is for NSE ₹ 44.60 & for BSE ₹ 45.45 as on Feb 27 2026 03:29 PM.

What is the Market Cap of Medico Remedies Ltd Share?

Answer Field

The market cap of Medico Remedies Ltd for NSE ₹ 369.50 & for BSE ₹ 0.00 as on Feb 27 2026 03:29 PM.

What is the 52 Week High and Low of Medico Remedies Ltd?

Answer Field

The 52 Week High and Low of Medico Remedies Ltd for NSE is ₹ 63.48 and ₹ 37.18 and for BSE is ₹ 64.11 and ₹ 35.00.

What is 1 year return for Medico Remedies Ltd?

Answer Field

The 1 year returns on the stock has been -10.94%.

What is the P/E Ratio of Medico Remedies Ltd Share?

Answer Field

As on Feb 27 2026 03:29 PM the price-to-earnings (PE) ratio for Medico Remedies Ltd share is 32.13.

What is the PB ratio of Medico Remedies Ltd Share?

Answer Field

As on Feb 27 2026 03:29 PM, the price-to-book (PB) ratio for Medico Remedies Ltd share is 8.05.

How to Buy Medico Remedies Ltd Share?

Answer Field

You can trade in Medico Remedies Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Medico Remedies Ltd Share on Bajaj Broking App?

Answer Field

To buy Medico Remedies Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Medico Remedies Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59